Emergence of Escherichia coli ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024
Author
Kohlenberg, Anke
Svartström, Olov
Apfalter, Petra
Hartl, Rainer
Bogaerts, Pierre
Huang, Te-Din
Eisfeld, Jessica
Sandfort, Mirco
Hammerum, Anette M
Roer, Louise
Räisänen, Kati
Dortet, Laurent
Bonnin, Rémy A
Tóth, Ákos
Tóth, Kinga
Clarke, Christina
Cormican, Martin
Griškevičius, Algirdas
Khonyongwa, Kirstin
Meo, Marie
Niedre-Otomere, Baiba
Vangravs, Reinis
Hendrickx, Antoni Pa
Notermans, Daan W
Samuelsen, Ørjan
Caniça, Manuela
Manageiro, Vera
Müller, Vilhelm
Mäkitalo, Barbro
Kramar, Urška
Pirs, Mateja
Palm, Daniel
Monnet, Dominique L
Alm, Erik
Linkevicius, Marius
Publication date
2024Published in
EurosurveillanceVolume / Issue
29 (47)ISBN / ISSN
ISSN: 1025-496XISBN / ISSN
eISSN: 1560-7917Metadata
Show full item recordCollections
This publication has a published version with DOI 10.2807/1560-7917.ES.2024.29.47.2400727
Abstract
Analysis of 594 isolates of Escherichia coli sequence type (ST)131 and its single locus variants carrying carbapenemase genes from 17 European Union/European Economic Area countries revealed acquisition of 18 carbapenemase variants, mainly in ST131 clades A and C. Most frequent were bla (OXA-244) (n = 230) and bla (OXA-48) (n = 224), detected in 14 and 12 countries, respectively. Isolates carrying bla (OXA-244) have increased rapidly since 2021. The increasing detection of carbapenemase genes in the E. coli high-risk lineage ST131 is a public health concern.
Keywords
Escherichia coli, ST131, antibiotic resistance, OXA-48-like
Permanent link
https://hdl.handle.net/20.500.14178/2722License
Full text of this result is licensed under: Creative Commons Uveďte původ 4.0 International